EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 17-Jun-2026 23:16 ET (18-Jun-2026 03:16 GMT/UTC)

Lung scans can reveal important differences in sarcoidosis severity according to new study

National Jewish Health
Peer-Reviewed Publication

A new study from researchers at National Jewish Health and collaborating institutions has found that different patterns seen on lung scans can signal how severe sarcoidosis may be, and how it affects breathing. The research was online published in the journal CHEST(Opens in a new window).

Lifestyle, diet, and clinical factors shape the gut microbiome in cancer patients

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — April 28, 2026 — A new review was published in Volume 13 of Oncoscience on March 11, 2026, titled “Associations among physical activity, diet, non-lifestyle characteristics and the gut microbiome of cancer patients: A scoping review and network analysis.”

Journal: Oncoscience

Sleep societies announce 2026 Inclusive Leadership Award recipient

American Academy of Sleep Medicine
Grant and Award Announcement

Sleep physician Dr. Indra Narang is the recipient of the 2026 Inclusive Leadership Award from the Associated Professional Sleep Societies, a joint initiative of the American Academy of Sleep Medicine and the Sleep Research Society.

Meeting: SLEEP 2026

Wild flatworms heal wounds

Lund University
Peer-Reviewed Publication

Researchers from Lund University in Sweden collected wild flatworms from Malmö’s largest park, Pildammsparken. These creatures are masters at regenerating after injury. Now, for the first time, the worms’ unique ability to regenerate has been harnessed to help accelerate wound healing in human skin models.

Journal: ACS Omega
Funder: The Swedish Research Council, The Crafoord Foundation, The Carl Trygger Foundation,, The Gyllenstierna Krapperup Foundation, The Magnus Bergvall Foundation

Age, sex, and cancer type influence risk of subsequent cancers among survivors

PLOS
Peer-Reviewed Publication

Risk of developing a subsequent primary cancer varied significantly by age at initial diagnosis, sex, and type of first cancer, according to a study by Oxana Palesh and Susan Hong and colleagues at Virginia Commonwealth University, U.S., published April 28^th in the open-access journal PLOS Medicine.

Journal: PLOS Medicine

Researchers spot shifts in firearm suicide risk and seeking treatment after 2020 purchasing surge

Rutgers University
Peer-Reviewed Publication

Individuals who died by firearm suicide following the 2020 firearm purchasing surge were more likely to be from racial minority groups, had higher rates of suicidal ideation and were less likely to have engaged in mental health treatment prior to their death, according to Rutgers University researchers.

Journal: Suicide and Life-Threatening Behavior

Mayo Clinic study finds bariatric surgery associated with greater long-term heart risk reduction than weight-loss medications

Mayo Clinic
Peer-Reviewed Publication

A Mayo Clinic study found that both metabolic and bariatric surgery and GLP-1 medications improve cardiovascular health in people with obesity, but surgery was associated with significantly greater reductions in long-term cardiovascular risk.

Journal: Annals of Surgery

Stopping and restarting certain GLP-1s to lose weight may make the drug less effective

University of Pennsylvania School of Medicine
Peer-Reviewed Publication

Inconsistent use of some GLP-1 weight-loss medications may significantly lessen their effectiveness, according to a new preclinical study.

Critical Path Institute awards $456,000 grant to advance next-generation therapy for rare glycolipid storage disorders

Critical Path Institute (C-Path)
Grant and Award Announcement

Critical Path Institute® today announced a $456,000 grant to James Shayman, M.D., at the University of Michigan, to support development of a brain-penetrant therapy for glycosphingolipid storage disorders. The award is part of C-Path’s Bridging Research and Innovation in Drug Development Grants (BRIDGe) program, offered through its Translational Therapeutics Accelerator.